1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

MDS - 955

Venetoclax Plus Hypomethylating Agent Improves Response Rates in High-Blast TP53-Mutated Myelodysplastic Syndromes

Michael Canonico

Poster Presenter: Michael Canonico

Thumbnail for Venetoclax With Chemotherapy in Consolidation in First Line Therapy T-Cell Acute Lymphoblastic Leukemia With MRD Persistence: Data RALL-2016m Study

ALL - 1182

Venetoclax With Chemotherapy in Consolidation in First Line Therapy T-Cell Acute Lymphoblastic Leukemia With MRD Persistence: Data RALL-2016m Study

Olga Aleshina

Poster Presenter: Olga Aleshina

Thumbnail for Venetoclax-Azacitidine Versus Intensive Chemotherapy for Induction in Childhood Acute Myeloid Leukemia: A Comparative Analysis

AML - 993

Venetoclax-Azacitidine Versus Intensive Chemotherapy for Induction in Childhood Acute Myeloid Leukemia: A Comparative Analysis

Shyam Srinivasan

Poster Presenter: Shyam Srinivasan

$Thumbnail for Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis$

AML - 923

Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis

Bhaswanth Bollu

Poster Presenter: Bhaswanth Bollu

AML - 283

Venetoclax-Based Therapy Is Associated With Improved Survival in Acute Myeloid Leukemia: A Large Real-World Study

Fareeha Abdulwali

Poster Presenter: Fareeha Abdulwali

Thumbnail for Venetoclax?in Combination With?a Hypomethylating Agent for Patients With?Newly Diagnosed Acute Myeloid Leukemia Who Are?Medically?Unfit for Intensive Induction Therapy: A Real-World Community Experience

AML - 384

Venetoclax?in Combination With?a Hypomethylating Agent for Patients With?Newly Diagnosed Acute Myeloid Leukemia Who Are?Medically?Unfit for Intensive Induction Therapy: A Real-World Community Experience

Chiara Perni

Poster Presenter: Chiara Perni

ABCL - 146

Venous Thromboembolism in Lymphoma: Risk Stratification and Evolving Anticoagulation Strategies

Swapnil Surpur

Poster Presenter: Swapnil Surpur

Thumbnail for Venous Thromboembolism Is Associated With Greater 90-Day Morbidity and Inpatient Utilization Among Hospitalized Patients With Diffuse Large B-Cell Lymphoma: A Propensity-Matched TriNetX Analysis

ABCL - 1615

Venous Thromboembolism Is Associated With Greater 90-Day Morbidity and Inpatient Utilization Among Hospitalized Patients With Diffuse Large B-Cell Lymphoma: A Propensity-Matched TriNetX Analysis

Mevlut Ozmen

Poster Presenter: Mevlut Ozmen

MPN - 672

Venous Thrombotic Outcomes in Pregnant Patients With Myeloproliferative Neoplasms: A Propensity Score-Matched Analysis

Rushi Shah

Poster Presenter: Rushi Shah